Zenocutuzumab is a novel bispecific antibody designed by Merus, N.V. In a multicenter global phase 2 clinical trial led by MSK gynecologic medical oncologist and early drug development specialist ...
We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Research at MSK Our research impact Research topics Core facilities & resources ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback